What taking health tests taught me about our future | David Ewing Duncan | TEDxMIT

Quick Overview

David Ewing Duncan details his "Experimental Man Project," a 24-year journey beginning in 2001 where he subjected himself to extensive biological testing to understand the connection between genetics, lifestyle, and health outcomes, ultimately illustrating the shift from reactive sick care to proactive wellness prediction using vast data sets and advanced AI.

Key Points: The Experimental Man Project spanned 2001-2025, accumulating approximately 70 Terabytes of data from thousands of tests across hundreds of labs. Testing included multi-omics (DNA, proteins), environmental toxin levels (1000+), MRI/CT scans of the brain and body, millions of immune cells, and data from wearables and advanced AI. In 2001, Duncan was assigned a 70% risk of heart attack in 20 years based on early genetic risk factors, but by actively managing his risk factors (like avoiding weight gain), he reduced this risk to 2%. He highlights the CYP1A2 gene variant, identifying him as a 'Caffeine Fast Metabolizer,' which allowed him to drink coffee late without sleep disruption. The speaker's immune system age, calculated using millions of immune cells and AI, scored as 20 years younger than his chronological age, achieving a BMM Score of 0.35. The presentation contrasts the old model of treating disease after symptoms appear with the future goal of predicting and preempting illness by integrating diverse biological data layers. Duncan's personal journey shifted from being a political writer to a science writer focused on these complex biological questions, leading him to actively test these new predictive health metrics.

Context: David Ewing Duncan, a science writer, recounts his decades-long "Experimental Man Project," which began in 2001 as an assignment to write about the Human Genome Project. Tired of traditional political reporting, he decided to turn himself into a living experiment, collecting massive amounts of personal biological data—ranging from genetics and metabolites to imaging scans and immune cell counts—to explore how these metrics could predict future health risks like heart disease and ultimately define personal identity.